Document Detail


Lymphoid malignancies: many tumor types, many altered genes, many therapeutic challenges.
MedLine Citation:
PMID:  23023709     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The lymphoid tissues, including both the B and T cell lineages, are characterized by a unique level of biological complexity due to the anatomical organization of functionally distinct cell subpopulations and complex processes of genetic alteration required to generate immune responses. Not surprisingly, this physiological diversity and complexity is mirrored by the broad spectrum of malignancies derived from lymphocytes. The articles in this Review Series highlight recent progress in selected common lymphoid malignancies, with a focus on the genetic alterations that drive malignant transformation, including those identified by genome-wide analyses. These genetic alterations represent the basis from which cellular pathways of therapeutic relevance can be identified, studied, and eventually targeted.
Authors:
Riccardo Dalla-Favera
Related Documents :
23696799 - Monoallelic chromatin conformation flanking long-range silenced domains in cancer-deriv...
23129629 - Non-bloom syndrome-associated partial and total loss-of-function variants of blm helicase.
21395709 - The effect of number of sows and service time of boars on selection response and inbree...
24449699 - Forward and reverse mutagenesis in c. elegans.
22215539 - Diagnostic challenges of mitochondrial disorders: complexities of two genomes.
15371529 - Evolutionary history of caenorhabditis elegans inferred from microsatellites: evidence ...
2993159 - Identification of a deletion in the low density lipoprotein (ldl) receptor gene in a pa...
8160739 - X-linked laterality sequence in a family with carrier manifestations.
18271929 - Epidermal growth factor receptor mutation, but not sex and smoking, is independently as...
Publication Detail:
Type:  Introductory Journal Article     Date:  2012-10-01
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  122     ISSN:  1558-8238     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-01     Completed Date:  2013-02-01     Revised Date:  2013-07-11    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3396-7     Citation Subset:  AIM; IM    
Affiliation:
Institute for Cancer Genetics, Columbia University, New York, New York 10032, USA. rd10@columbia.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Leukemia, Lymphoid* / etiology,  genetics,  pathology,  therapy
Lymphoma* / etiology,  genetics,  pathology,  therapy
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.
Next Document:  The molecular basis of T cell acute lymphoblastic leukemia.